Lynn E Taylor

Summary

Affiliation: Rhode Island Hospital
Country: USA

Publications

  1. pmc Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk
    L E Taylor
    Department of Medicine, Division of Infectious Disease, Brown University, Providence, Rhode Island 02906, USA
    AIDS Patient Care STDS 25:571-7. 2011
  2. doi Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?
    Lynn E Taylor
    The Warren Alpert Medical School of Brown University Miriam Hospital, 164 Summit Avenue, Center for AIDS Research Building Room 156, Providence, RI 02906, USA
    J Addict Med 6:179-85. 2012
  3. pmc HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms
    Lynn E Taylor
    Department of Medicine, Brown University, Providence, RI 02906, USA
    Clin Infect Dis 55:S33-42. 2012
  4. doi Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy
    Lynn E Taylor
    The Warren Alpert Medical School of Brown University, USA
    Drug Alcohol Depend 116:233-7. 2011
  5. pmc Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials
    Lynn E Taylor
    Department of Medicine, Brown University, Providence, Rhode Island, USA
    Clin Infect Dis 52:812-8. 2011
  6. ncbi Delivering care to injection drug users coinfected with HIV and hepatitis C virus
    Lynn E Taylor
    Department of Medicine, Division of Infectious Disease, Brown Medical School, Providence, Rhode Island, USA
    Clin Infect Dis 40:S355-61. 2005
  7. ncbi Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence
    Lynn E Taylor
    The Miriam Hospital, Providence, RI, USA
    Clin Infect Dis 36:1501-2; author reply 1502-3. 2003
  8. pmc A syringe prescription program to prevent infectious disease and improve health of injection drug users
    Josiah D Rich
    School of Medicine at Brown University, The Miriam Hospital, 164 Summit Avenue, Providence, RI 02906, USA
    J Urban Health 81:122-34. 2004
  9. pmc Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C
    Kara W Chew
    Department of Medicine, University of California at San Francisco, San Francisco, CA 94115, USA
    J Clin Gastroenterol 43:686-91. 2009
  10. ncbi Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report
    Lynn E Taylor
    Department of Medicine, Division of Infectious Disease, Brown Medical School, Providence, RI, USA
    AIDS Read 15:629-31, 634-6, 638. 2005

Detail Information

Publications26

  1. pmc Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk
    L E Taylor
    Department of Medicine, Division of Infectious Disease, Brown University, Providence, Rhode Island 02906, USA
    AIDS Patient Care STDS 25:571-7. 2011
    ..Tracking quarterly ALT for elevation to systematically prompt HCV RNA testing before seroconversion is a promising approach to screen for acute HCV in a real-world HIV clinical setting...
  2. doi Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?
    Lynn E Taylor
    The Warren Alpert Medical School of Brown University Miriam Hospital, 164 Summit Avenue, Center for AIDS Research Building Room 156, Providence, RI 02906, USA
    J Addict Med 6:179-85. 2012
    ..Buprenorphine facilitates hepatitis C virus (HCV) treatment in opioid-dependent patients with HCV monoinfection. Less is known about buprenorphine's role in HIV/HCV coinfection...
  3. pmc HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms
    Lynn E Taylor
    Department of Medicine, Brown University, Providence, RI 02906, USA
    Clin Infect Dis 55:S33-42. 2012
    ..HCV drug trials in individuals coinfected with HIV should be expedited. HIV/HCV coinfection remains a growing and evolving epidemic; new developments in therapeutics and improved care models offer promise...
  4. doi Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy
    Lynn E Taylor
    The Warren Alpert Medical School of Brown University, USA
    Drug Alcohol Depend 116:233-7. 2011
    ..HCV therapy for HCV-monoinfected methadone maintenance (MM) recipients is safe and effective. We evaluated treatment efficacy and adherence to pegylated interferon (pegIFN) among HIV/HCV coinfected MM recipients...
  5. pmc Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials
    Lynn E Taylor
    Department of Medicine, Brown University, Providence, Rhode Island, USA
    Clin Infect Dis 52:812-8. 2011
    ..Whether this is occurring across the United States is unknown...
  6. ncbi Delivering care to injection drug users coinfected with HIV and hepatitis C virus
    Lynn E Taylor
    Department of Medicine, Division of Infectious Disease, Brown Medical School, Providence, Rhode Island, USA
    Clin Infect Dis 40:S355-61. 2005
    ..Presented here is a work in progress, rather than a finished research project or definitive model of care...
  7. ncbi Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence
    Lynn E Taylor
    The Miriam Hospital, Providence, RI, USA
    Clin Infect Dis 36:1501-2; author reply 1502-3. 2003
  8. pmc A syringe prescription program to prevent infectious disease and improve health of injection drug users
    Josiah D Rich
    School of Medicine at Brown University, The Miriam Hospital, 164 Summit Avenue, Providence, RI 02906, USA
    J Urban Health 81:122-34. 2004
    ..The syringe prescription program in Providence represents a promising and innovative approach to disease prevention and treatment for IDUs...
  9. pmc Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C
    Kara W Chew
    Department of Medicine, University of California at San Francisco, San Francisco, CA 94115, USA
    J Clin Gastroenterol 43:686-91. 2009
    ..To report our experience with pegylated interferon and ribavirin treatment of hepatitis C virus (HCV) RNA-positive inmates at the Rhode Island Department of Corrections...
  10. ncbi Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report
    Lynn E Taylor
    Department of Medicine, Division of Infectious Disease, Brown Medical School, Providence, RI, USA
    AIDS Read 15:629-31, 634-6, 638. 2005
    ..This case suggests that HIV-HCV-coinfected persons with the common comorbidities of polysubstance dependence and psychiatric illness may effectively and safely undergo pharmacotherapy for hepatitis C with appropriate support...
  11. ncbi Prescribing syringes to injection drug users with HIV: an important clinical and public health tool
    Michelle A Stozek
    Brown University, Providence, Rhode Island, USA
    J Assoc Nurses AIDS Care 15:59-63. 2004
  12. ncbi Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection
    Timothy P Flanigan
    Department of Medicine, The Miriam Hospital, Brown University School of Medicine, Providence, Rhode Island 02906, USA
    Clin Infect Dis 40:S346-8. 2005
    ..DOT can both optimize adherence and provide a way to offer psychosocial support and linkages to social, addiction, psychiatric, and other services, to help address many of the challenges faced by persons with substance abuse disorders...
  13. ncbi Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus
    Andrew R Lai
    Brown Medical School, Providence, Rhode Island, USA
    AIDS Patient Care STDS 20:678-92. 2006
    ..We review the current data on the use of antiretrovirals in HIV/HCV-coinfected patients and offer evidence-based recommendations on optimal selection and dosing of antiretroviral agents for this population...
  14. pmc Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy
    Lynn E Taylor
    Department of Medicine, Brown University, Providence, Rhode Island, USA
    Clin Infect Dis 57:S118-24. 2013
    ..The ultimate goal must be the elimination of HCV from all coinfected PWID. ..
  15. ncbi Would you consider prescribing syringes to injection drug users? Addiction Medicine Conference Survey
    Lynn E Taylor
    The Miriam Hospital andBrown University, Providence, RI 02906, USA
    J Addict Dis 22:67-78. 2003
    ..The majority of physicians surveyed expressed interest in prescribing syringes. Psychiatrists may be less willing to do so...
  16. doi The Spectrum of Undiagnosed Hepatitis C Virus Infection in a US HIV Clinic
    Lynn E Taylor
    1 Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island
    AIDS Patient Care STDS 28:4-9. 2014
    ..Adding annual rescreening to the Ryan White Program would facilitate earlier identification of undiagnosed HCV and create an instant widespread surveillance system, providing HCV incidence data. ..
  17. ncbi Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island
    Josiah D Rich
    Brown Medical School, and The Miriam Hospital, Providence, Rhode Island 02906, USA
    J Am Pharm Assoc (Wash) 42:S58-61. 2002
    ..To examine pharmacists' attitudes and obstacles to syringe sales to IDUs without prescriptions in Rhode Island, around the time that such sales became legal in the state...
  18. ncbi Twinrix vaccination schedules among injecting drug users
    Nancy Brim
    Brown Medical School, Providence, Rhode Island, USA, 2The Miriam Hospital, 164 Summit Ave, Providence, RI 02906, USA
    Expert Opin Biol Ther 7:379-89. 2007
    ..The authors conclude that there is insufficient evidence regarding whether the accelerated Twinrix HAV/HBV vaccination schedule would yield a greater number of IDUs protected against both HAV and HBV...
  19. ncbi Ten things you may not know about hepatitis C infection
    Edward Feller
    Brown Medical School, Division of Gastroenterology, Miriam Hospital Division of Gastroenterology, 164 Summit Ave, Providence, RI 02906, USA
    Med Health R I 85:180-1. 2002
  20. ncbi Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients
    Barbara H McGovern
    HIV HCV Co infection Clinic, Lemuel Shattuck Hospital, Jamaica Plain, Jamaica Plain, MA 02494, USA
    Clin Infect Dis 43:365-72. 2006
    ....
  21. ncbi Peginterferon plus ribavirin for hepatitis C in HIV-infected patients
    Lynn E Taylor
    N Engl J Med 351:2340-2; author reply 2340-2. 2004
  22. ncbi Treatment of chronic hepatitis C in a state correctional facility
    Scott A Allen
    Rhode Island Department of Corrections, 39 Howard Avenue, Cranston, RI 02920, USA
    Ann Intern Med 138:187-90. 2003
    ..Currently, there are few reports of treatment outcomes of this common infection in this setting...
  23. ncbi Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals
    Lynn E Taylor
    AIDS 16:1700-1. 2002
  24. ncbi Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study
    Norbert Brau
    Bronx Veterans Affairs VA Medical Center, Infectious Disease Section 111F, 130 West Kingsbridge Road, Bronx, NY 10468, USA
    J Hepatol 47:527-37. 2007
    ..HIV-infected patients now live longer and often have complications of liver disease, especially with hepatitis B or C virus coinfection. Limited data are available on those with hepatocellular carcinoma (HCC)...
  25. ncbi Screening for hepatitis C virus infection in adults
    Josiah D Rich
    Ann Intern Med 141:575-6; author reply 576. 2004
  26. ncbi Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection
    Jason T Blackard
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Med Virol 78:202-7. 2006
    ..These data suggest that a defect in cytokine activation may occur in HCV/HIV co-infected persons that limits efficient clearance of HCV from the liver...